Jim Cramer: Allergan Would Be at $120 If Valeant Wasn't Involved - Presented by: The Aol. On Network

TheStreet's Jim Cramer asks investors if Allergan has the ability to fight off Valeant. Cramer will be talking to David Pyott, CEO of Allergan, later today. Cramer finds it quite clear that Allergan is basing a lot of its independence on it's pipeline and he believes that if the pipeline is not as good as Pyott said it was, then investors are going to take their money and run.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.15 0.01 ▼ 0.06%
AAPL $ 101.035 0.46 ▲ 0.45%
CRM $ 60.35 4.64 ▲ 8.33%
QQQ $ 99.07 0.17 ▲ 0.17%
JRJC $ 10.6899 0.95 ▲ 9.75%
FB $ 74.4626 0.11 ▼ 0.14%
C $ 50.92 0.15 ▼ 0.29%
PBR $ 17.10 0.63 ▼ 3.55%

As of 8/22/2014, 02:08 PM
More Most Active